查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067459

金奈米顆粒市場：依製造流程、應用、最終用途、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Gold Nanoparticles Market, By Process, By Application, By End Use, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 372 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，金奈米顆粒市場價值將達到 92.388 億美元，並預計從 2026 年到 2033 年將以 11.1% 的複合年成長率成長。

金奈米顆粒是指尺寸約1-100奈米的金顆粒。它們具有與純金顯著不同的獨特光學、電子和催化特性，並被廣泛應用於生物醫學成像、藥物傳遞和感測等領域。由於市場對更先進的奈米醫學應用（例如個人化診斷和標靶遞送）的需求不斷成長，金奈米顆粒市場正在穩步擴張。 2025年，Cytodiagnostics專注於為金奈米顆粒市場中先進奈米醫學應用的發展提供技術支援。該公司透過提供主要用於檢測方法開發和奈米級生物醫學實驗的金奈米顆粒研究平台，贏得了早期應用開發人員的信賴。因此，Cytodiagnostics在先進奈米醫學研究和標靶診斷領域正扮演著越來越重要的角色。

金奈米顆粒市場－市場動態

生物醫學研究經費的增加正在推動市場需求。

隨著生物醫學研究經費的增加，臨床研究、轉化科學和醫療創新領域的資助尤為顯著成長。隨著新疾病威脅的出現和對快速科學進步的需求，研究津貼津貼政策正轉向更加重視應對感染疾病和慢性病。尤其值得一提的是，加強研究基礎建設和透過跨機構合作擴大對青年研究人員的資助力度，已成為一項日益重要的工作。

此外，鑑於目前奈米技術在診斷、標靶藥物遞送和治療方法研究等具有巨大應用潛力的領域正獲得大量投資，生物醫學研究的投入預計也將推動金奈米顆粒市場的發展。例如，據印度政府（生物技術部與惠康基金會夥伴關係）稱，印度正在大幅增加對生物醫學研究的投資，截至2025年10月，生物醫學研究職業發展計畫（BRCP）的總預算約為1.8億美元。這項投資旨在利用金奈米顆粒提升生物醫學研究能力，加速醫學創新，並透過支持至少2,000名研究人員（包括青年科學家、博士後和臨床研究人員）在各個領域開展研究，從而加強印度的研究基礎設施。

金奈米顆粒市場－市場區隔分析：

全球金奈米顆粒市場按製造流程、應用、最終用途和地區進行細分。

在製造過程方面，化學合成佔據了金奈米顆粒市場的大部分佔有率。這是因為化學合成能夠生產高純度、粒徑均勻且可大規模生產的金奈米顆粒，使其在生物醫學、診斷和奈米技術領域中廣泛應用。例如，根據歐洲化學工業聯合會（Cefic.org）的數據，德國化學和製藥業的銷售額高達2,450億美元，是該國第三大產業部門，直接支撐著約2,100家公司提供的約47.95萬個就業機會。這充分體現了德國對化學合成的依賴以及工業化學生態系統的蓬勃發展。

從應用角度來看，成像技術在金奈米顆粒市場中佔據了很大的佔有率，這得益於其廣泛的應用，包括生物醫學領域的高解析度成像、癌症診斷中的造影成像以及提高疾病檢測的準確性和靈敏度。例如，根據Pubs.ACS Nano 2026年的一項調查，Org的一項調查顯示，基於奈米顆粒的成像系統具有多種主要生物醫學成像模式共存的特點，例如磁振造影（MRI）、電腦斷層掃描（CT）、螢光成像和光聲成像。然而，用於多模態成像的奈米顆粒平台已在四種或更多臨床相關的主要成像工作流程中展現出其有效性，包括光學成像、磁振造影、X光成像和混合分子成像系統。因此，這支持了多模態奈米顆粒成像在先進生物醫學診斷中更廣泛的應用。

金奈米顆粒市場—區域分析

北美憑藉其高度發展的醫療設施和研發生態系統，在金奈米顆粒市場佔據了相當大的佔有率。根據美國醫院協會（AHA）預測，到2026年，美國將擁有高度發展的醫療基礎設施，包括遍布全國的約6100家醫院，並由龐大而複雜的醫療服務網路提供支援。這些醫院共運作超過90.7萬張固定床位，構成了大規模的全國性住院醫療系統。該系統每年服務超過3560萬名住院患者，這反映了美國醫院服務的規模和高利用率。因此，高品質醫院和診所的存在確保了使用微粒的新治療方法將繼續廣泛應用。

亞太地區金奈米顆粒市場的主要驅動力是亞洲開發中國家醫療保健支出的成長。例如，根據世界銀行和世界衛生組織（世衛組織）2025年12月發布的全球醫療保健支出資料庫，截至2025年12月，醫院和其他醫療機構的支出僅佔中國當前醫療保健支出的32.2%。因此，中國家庭承擔的高額自付醫療費用表明，日常醫療保健成本是一項沉重的負擔。醫療保健淨支出佔GDP的比例維持在5.9%，顯示社會經濟領域持續成長。這促使醫療保健覆蓋範圍擴大，並推動各國大力發展和改善醫療保健基礎設施及服務。因此，隨著醫療保健支出的成長，對利用奈米技術的先進醫療應用的需求預計也將持續上升。

英國金奈米顆粒市場—國家概況

隨著奈米技術的進步和製藥業的蓬勃發展，英國對金奈米顆粒的需求預計將會成長。英國投資者正在加大對奈米醫學研發的投入，金奈米顆粒也擴大被用作生物利用度高的藥物遞送載體。例如，根據英國製藥商和貿易協會（ABPI）預測，到2026年，英國英國業將為國民經濟貢獻約237.6億美元的直接增加價值（GVA），並在研發方面投入約125.55億美元。因此，製藥公司對研發的大量投入將催生新的金奈米顆粒技術，並進一步拓展其應用範圍。

目錄

第1章：金奈米顆粒市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：金奈米粒子市場的主要趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：金奈米顆粒產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章 金奈米顆粒市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：金奈米顆粒市場現狀

  • 金奈米顆粒市場佔有率分析（2025年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 金奈米顆粒市場：依製程分類

  • 概述
    • 基於細分市場的市場佔有率分析：按流程
    • 化學品
    • 身體的
    • 綠色/生物合成
    • 種子介導生長
    • 連續流和微流體

第8章 金奈米顆粒市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 影像
    • 標靶藥物遞送
    • 質子束療法
    • 體外試驗
    • 感測器、探頭
    • 催化作用
    • 其他

第9章 金奈米顆粒市場：依最終用途分類

  • 概述
    • 按最終用途分類的市佔率分析。
    • 藥品和醫療保健
    • 化學品和催化劑
    • 能源與環境
    • 電子和半導體
    • 個人護理化妝品
    • 其他

第10章 金奈米顆粒市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章：主要供應商分析：金奈米顆粒產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Cytodiagnostics Inc.
    • Goldsol Inc.
    • BBI Solutions
    • NanoHybrids Inc.
    • Nanopartz Inc.
    • Nanosphere Inc.
    • Nanostellar Inc.
    • Solaris Nanosciences Corporation
    • TANAKA Holdings Co., Ltd.
    • The Metalor Group
    • Sigma-Aldrich
    • Abcam plc
    • Aurion
    • Creative Diagnostics
    • Johnson Matthey Plc
    • Meliorum Technologies Inc.
    • Merck KGaA
    • nanoComposix
    • Sona Nanotech Inc.
    • Others

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV6719

Gold Nanoparticles market size was valued at US$ 9,203.88 Million in 2025, expanding at a CAGR of 11.1% from 2026 to 2033.

Gold nanoparticles are particles of gold with a size close to 1-100 nm. They have certain optical, electronic, and catalytic properties that are entirely different from bulk gold and can be used in a wide variety of fields, including biomedical imaging, drug delivery, and sensing. The market for gold nanoparticles is expanding at a steady rate due to an increasing market demand for more sophisticated nanomedicine applications, including personalized diagnostics and targeted delivery. In 2025, Cytodiagnostics Inc. focused on providing technology support to facilitate the development of advanced nanomedicine applications in the gold nanoparticle market. They did this by providing their gold nanoparticle-based research platforms, which are predominantly used in assay development and nanoscale biomedical experiments, to gain credibility with the early developers of applications for targeted diagnostics and advanced nanomedicine. Hence, cytodiagnostics is becoming more important in advanced nanomedicine research and targeted diagnostics.

Gold Nanoparticles Market- Market Dynamics

Rising biomedical research funding driving market demand

There has been a rise in grant issuance for increasing biomedical research funding, especially for clinical research and translational science as well as healthcare innovation. Research grant protocols are now more adapted towards infectious and chronic diseases as new threats of diseases emerge demanding rapid scientific advancement. Special importance is given to a stronger research infrastructure and increased funding for young investigators through multi-institutional collaborations.

The biomedical research spending is also projected to boost the Gold Nanoparticles market as a number of investments are made in various applications, such as diagnostics, target drug delivery, and research in therapeutics in the current era, which have the potential of nanotechnology. For example, India has considerably increased investment in biomedical research, according to the Government of India (Department of Biotechnology and Wellcome Trust partnership), with the Biomedical Research Career Programme (BRCP) having a total budget of about USD 180 million in October 2025. In order to consolidate the national research infrastructure by supporting a minimum of 2,000 researchers, including early-stage scientists, post-docs, and clinical researchers from a diverse range of disciplines, this investment is put forth to enhance the biomedical research capabilities and accelerate health care innovations involving gold nanoparticles.

Gold Nanoparticles Market- Segmentation Analysis:

The Global Gold Nanoparticles market is segmented on the basis of Process, Application, End Use, and Region.

Under 'By Process,' chemical synthesis holds a significant share in the Gold Nanoparticles market because it has high usage purity with similarly sized particles and mass-producing scale; hence, it is most widely used in biomedical science, diagnostics, and nanotechnology. For instance, according to Cefic.org, Germany's chemical and pharmaceutical industry generated a turnover of USD 245,000 million, making it the third-largest industrial sector in the country while directly supporting around 479,500 jobs across ~2,100 companies. So this shows heavy dependence on chemical synthesis and the growth of industrial chemical ecosystems.

Based on application focus, imaging holds a prominent share in the gold nanoparticle market due to the broad spectrum of imaging uses, such as biomedical high-resolution imaging, contrast imaging in cancer diagnosis, enhancement in disease detection accuracy and sensitivity, and others. As an example, in 2026 it was identified by the research compiled by Pubs.ACS Nano.Org that the feature of nanoparticle-based imaging systems now represents a coexistent variety of predominant biomedical imaging modalities, including MRI, CT, fluorescence imaging, photoacoustic imaging, etc., but multimodal imaging nanoparticle platforms have already been demonstrated in more than 4 major clinically relevant imaging workflows, including optical, magnetic, X-ray, and hybrid molecular imaging systems. Thus, this supports the growing use of multimodal nanoparticle imaging in advanced biomedical diagnostics.

Gold Nanoparticles Market- Geographical Insights

North America holds a significant share in the Gold Nanoparticles market, owing to the presence of well-developed healthcare facilities and R&D ecosystems within the region. In 2026, as stated by the American Hospital Association (AHA) org., the United States maintains a highly developed healthcare infrastructure comprising approximately 6,100 hospitals nationwide, supported by a large and complex network of care delivery systems. These hospitals collectively operate more than 907,000 staffed hospital beds, enabling large-scale inpatient care capacity across the country. The system handles a significant patient load, with total annual admissions exceeding 35.6 million patients, reflecting the scale and utilization intensity of U.S. hospital services. So, good hospitals and clinics help make sure that new treatments using tiny particles keep being used often.

The Asia Pacific Gold Nanoparticles market is mainly driven by increasing healthcare expenditure in developing Asian countries. For instance, according to the recent World Bank and Global Health Expenditure database of the World Health Organization in Dec 2025, the percentage share of China's current health expenditure contributed by the hospitals and other healthcare establishments remains at 32.2%; as a result, above out-of-pocket payments by Chinese households indicate the heavy burden of day-to-day medical expenses. The net current health expenditure as a percentage of the GDP still remains at 5.9%, demonstrating continued growth in continuing increases in the socioeconomic sectors, which, hence, increase extended healthcare coverage and great efforts to promote and improve the health care infrastructure and also the health service sector at an extensive rate in the country. Hence, money is spent on healthcare; there will be ongoing demand for advanced medical uses of nanotechnology.

UK Gold Nanoparticles Market- Country Insights

The UK's demand for gold nanoparticles is predicted to grow with advances in nanotechnology along with the developed pharmaceutical industry. UK investors are funding more research on nanomedicine, and gold nanoparticles are increasingly used as bioavailable drug delivery agents. For instance, in 2026, according to the Association of the British Pharmaceutical Industry (ABPI), the UK pharmaceutical industry contributed approximately USD 23,760 million in direct gross value added (GVA) to the national economy and invested approximately USD 12,555 million in research and development (R&D). So, when drug companies invest heavily in research and development, it helps create new gold nanoparticle technologies and makes them more widely used.

Gold Nanoparticles Market- Competitive Landscape:

The competitive landscape of the gold nanoparticle industry, measured by the presence of innovative companies like Johnson Matthey, TANAKA Holdings, Merck KGaA, Cytodiagnostics, and Sona Nanotech, is strengthening its market position by developing nanoparticle synthesis, surface functionalization techniques, and high-purity products. The companies are investing in new technologies based on R&D, new personalized products, and a long-term development strategy with the pharma, diagnostics, sensing, and electronics industries. For instance, in May 2025, Sona Nanotech enhanced its gold nanorod-based Targeted Hyperthermia Therapy (THT) platform in terms of supporting clinical progression of biocompatible gold nanorods for cancer tissue treatment efficiency, thereby boosting the commercialization potential of gold nanorods technically and enhancing Sona Nanotech's market position in therapeutic nanotechnology applications. Therefore, high-quality medical nanotechnology creates more business opportunities and enhances competitive market position.

Recent Developments:

In March 2026, Metalor Technologies, a TANAKA Group company, completed the acquisition of Gannon & Scott, a North American precious metals refining and recycling company. The acquisition expands TANAKA's precious metals recycling capabilities, strengthens raw material sourcing channels, and enhances its position in gold-related materials and nanoparticle supply chains.

In May 2025, Merck KGaA announced a strategic partnership with imec to develop next-generation microphysiological systems (MPS)-on-a-chip platforms, leveraging advanced materials, nanoengineering, and AI-enabled research capabilities to improve drug discovery and preclinical testing. The partnership enhances Merck KGaA's position in advanced nanotechnology-enabled life science solutions, accelerates innovation in precision research platforms, and expands opportunities for nanoparticle-based biomedical applications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GOLD NANOPARTICLES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Cytodiagnostics Inc.
  • Goldsol Inc.
  • BBI Solutions
  • NanoHybrids Inc.
  • Nanopartz Inc.
  • Nanosphere Inc.
  • Nanostellar Inc.
  • Solaris Nanosciences Corporation
  • TANAKA Holdings Co., Ltd.
  • The Metalor Group
  • Sigma-Aldrich
  • Abcam plc
  • Aurion
  • Creative Diagnostics
  • Johnson Matthey Plc
  • Meliorum Technologies Inc.
  • Merck KGaA
  • nanoComposix
  • Sona Nanotech Inc.
  • Others

GLOBAL GOLD NANOPARTICLES MARKET, BY PROCESS- MARKET ANALYSIS, 2020 - 2033

  • Chemical
  • Physical
  • Green/Biological Synthesis
  • Seed-mediated Growth
  • Continuous Flow and Microfluidic

GLOBAL GOLD NANOPARTICLES MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Imaging
  • Targeted Drug Delivery
  • Proton Therapy
  • In-vitro Assays
  • Sensors, Probes
  • Catalysis
  • Others

GLOBAL GOLD NANOPARTICLES MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033

  • Pharmaceutical & Healthcare
  • Chemicals and Catalysts
  • Energy and Environmental
  • Electronics and Semiconductors
  • Personal Care & Cosmetics
  • Others

GLOBAL GOLD NANOPARTICLES MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Gold Nanoparticles Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Gold Nanoparticles Market Snippet by Process
    • 2.1.2. Gold Nanoparticles Market Snippet by Application
    • 2.1.3. Gold Nanoparticles Market Snippet by End Use
    • 2.1.4. Gold Nanoparticles Market Snippet by Country
    • 2.1.5. Gold Nanoparticles Market Snippet by Region
  • 2.2. Competitive Insights

3. Gold Nanoparticles Key Market Trends

  • 3.1. Gold Nanoparticles Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Gold Nanoparticles Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Gold Nanoparticles Market Opportunities
  • 3.4. Gold Nanoparticles Market Future Trends

4. Gold Nanoparticles Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Gold Nanoparticles Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Gold Nanoparticles Market Landscape

  • 6.1. Gold Nanoparticles Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Gold Nanoparticles Market - By Process

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Process, 2025 & 2033 (%)
    • 7.1.2. Chemical
    • 7.1.3. Physical
    • 7.1.4. Green/Biological Synthesis
    • 7.1.5. Seed-mediated Growth
    • 7.1.6. Continuous Flow and Microfluidic

8. Gold Nanoparticles Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Imaging
    • 8.1.3. Targeted Drug Delivery
    • 8.1.4. Proton Therapy
    • 8.1.5. In-vitro Assays
    • 8.1.6. Sensors, Probes
    • 8.1.7. Catalysis
    • 8.1.8. Others

9. Gold Nanoparticles Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
    • 9.1.2. Pharmaceutical & Healthcare
    • 9.1.3. Chemicals and Catalysts
    • 9.1.4. Energy and Environmental
    • 9.1.5. Electronics and Semiconductors
    • 9.1.6. Personal Care & Cosmetics
    • 9.1.7. Others

10. Gold Nanoparticles Market - By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Gold Nanoparticles Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Gold Nanoparticles Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Gold Nanoparticles Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Gold Nanoparticles Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Gold Nanoparticles Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Process, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Gold Nanoparticles Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Cytodiagnostics Inc.
    • 11.2.2. Goldsol Inc.
    • 11.2.3. BBI Solutions
    • 11.2.4. NanoHybrids Inc.
    • 11.2.5. Nanopartz Inc.
    • 11.2.6. Nanosphere Inc.
    • 11.2.7. Nanostellar Inc.
    • 11.2.8. Solaris Nanosciences Corporation
    • 11.2.9. TANAKA Holdings Co., Ltd.
    • 11.2.10. The Metalor Group
    • 11.2.11. Sigma-Aldrich
    • 11.2.12. Abcam plc
    • 11.2.13. Aurion
    • 11.2.14. Creative Diagnostics
    • 11.2.15. Johnson Matthey Plc
    • 11.2.16. Meliorum Technologies Inc.
    • 11.2.17. Merck KGaA
    • 11.2.18. nanoComposix
    • 11.2.19. Sona Nanotech Inc.
    • 11.2.20. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us